Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06636006

Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia

Effects of Aerobic Exercise Versus Digital Cognitive Behavioral Therapy for Insomnia in University Students With Insomnia Complaints

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Universidade Federal de Goias · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effects of aerobic exercise versus digital CBT-I in university students with insomnia complaints. This is a clinical trial. Participants will be randomized into two groups: aerobic exercise (n=25) and digital CBT-I (n=25). The severity of insomnia, sleep quality, pre-sleep cognitive and somatic arousal, and participants' complaints of depression, anxiety, and stress will be assessed using self-administered questionnaires. Based on previous studies describing the effects of physical exercise on chronic insomnia, the hypothesis of this study is that aerobic exercise promotes similar results compared to digital CBT-I in insomnia severity and sleep quality, in addition to improving the complaints of depression, anxiety and stress of the participants.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAerobic Exercise50 continuous minutes, at moderate intensity (Identified by the Borg Subjective Perception of Exertion Scale, scores from 12 to 13)
BEHAVIORALCognitive Behavioral Therapy for InsomniaCBT-I includes some therapies, including sleep restriction therapy, stimulus control therapy, sleep hygiene education, relaxation and cognitive therapy\[19\]. Traditionally, CBT-I is applied in person (individually or in a group) by a trained psychologist or psychiatrist. However, several studies show similar effects when CBT-I is performed remotely, and online (digital)

Timeline

Start date
2024-10-10
Primary completion
2025-12-30
Completion
2026-12-30
First posted
2024-10-10
Last updated
2025-03-25

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT06636006. Inclusion in this directory is not an endorsement.